Vipul Jairath

Chief Medical Officer

Vipul oversees the global Medical R&D initiatives and services. In conjunction with the executive team and senior medical advisors, he assumes overall responsibility for research strategy, as well as performance of the organization’s Medical R&D services including medical operations, medical imaging, precision medicine, medical writing, medical monitoring, medical/biostatics advisory collaborations and IBD fellowships. He also provides medical oversight for the design of clinical trials, protocol development and imaging R&D endpoints. Vipul was previously VP Medical Research & Development (2019-2021) and Director of Academic Research and Development (2016-19).

Background

Dr Jairath obtained his BSc (Pharmacology) and Medical Degree from the University of Leeds (UK), DPhil (PhD) in Clinical Medicine from the University of Oxford and post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine. He is Professor of Medicine at the Schulich School of Medicine and Dentistry, and holder of the John and Susan McDonald Endowed Chair in Inflammatory Bowel Disease (IBD) at Western University.

His specialist clinical training in Gastroenterology was completed in London and Oxford, and he holds specialist certification in both Ontario and the UK. Prior to moving to Western in 2016, he was a National Institute for Health Research Clinical Trials Fellow at the Oxford Clinical Trials Research Unit and Consultant Gastroenterologist at Oxford University hospitals.

He is a practising gastroenterologist and specialist in inflammatory bowel disease, and his research interests in clinical therapeutics for IBD include design of clinical trials, development and validation of outcome measures for use in clinical trials, patient reported outcome measures and prediction modelling for response to therapy.

Achievements

Vipul has driven the development and validation of several novel indices for use in IBD clinical trials, like the UC-100 and the novel patient reported outcome measures, SIQ-UC and SIQ-CD. In addition, he was instrumental to the delivery of the REACT2 trial and to the design of the VERDICT trial, both of which are important clinical practice questions for patients with Crohn’s Disease and Ulcerative Colitis, respectively.

Ethos

“We are what we repeatedly do. Excellence, then, is not an act, but a habit.” — Aristotle

View Profile
Martin Ladouceur

Vice President, Real-World Evidence

Martin leads and oversees the growth, scientific service offerings, and consulting of the newly formed Real-World Evidence (RWE) Unit. Subject matter expert in RWE methodology, he focuses on bringing scientific evidence to clients build around fit-for-purpose study design and the use of real-world data.

Background:

Methodologist specialized in health research, he offers over 15 years of applied experience in clinical research and consulting. Trained at McGill University where he obtained his doctoral degree in Epidemiology and Biostatistics, Martin also pursued postdoctoral training in statistical genetics at the Montreal Jewish Hospital, Erasmus MC Rotterdam, University of Toronto, and INSERM Paris. Before joining Alimentiv, Martin was the Director of Statistics RWE and Senior Research Scientist at Evidera-PPD, where he led the external control arm initiative, act as the scientific oversight on a large portfolio of projects and contributed to the strategic direction. Through his many leadership roles both in academia and industry, Martin developed an expertise as a consultant on methodological design. He managed different types of studies such as external control arm, chart reviews, prospective study, matching-adjusted indirect comparisons, retrospective studies using administrative databases, clinical trials, and targeted literature reviews. Martin also served as the principal consultant at an academic research hospital (CR-CHUM) where he collaborated with clinicians and researchers on all aspects of clinical research projects (consulting, design, protocols, grant applications, disseminations). Martin taught several graduate biostatistics classes at McGill and Montreal University. He is also an adjunct clinical professor at Montreal University at the School of Public Health in the department of social and preventive medicine.

Achievements

His collaborative work led to several financial supports from major granting agencies such as the National Institute of Health, the Canadian Institute of Health Research, Cystic Fibrosis Foundation, Canadian Diabetes Association, and Genome Canada and many published works in top journals such as Lancet Diabetes, Lancet, PLoS Genetics, Statistics in Medicine, Prostate, Radiology, and European Journal of Genetics. Martin has proven ability to think strategically and has a reputation of understanding the problems that collaborators are bringing to his attention.

Ethos

I will not follow where the path may lead, but I will go where there is no path, and I will leave a trail. (Muriel Strode, Poet. The poem was printed in the journal “The Open Court” in August 1903)

View Profile
Wendy Teft

Director, Precision Medicine

Wendy provides leadership and oversight to the global activities and timelines related to precision medicine for sponsor clinical trials and research and development projects.

Background

Wendy obtained her PhD in Immunology at the University of Western Ontario and completed a Post-doctoral fellowship in Personalized Medicine focused on optimizing treatment strategies for oncology and inflammatory bowel disease patients. She has 10+ years of experience working with clinicians, scientists, and pharmaceutical organizations across multiple functions to implement the use of individually tailored therapies in the clinic and to support the identification of biomarkers during clinical drug development.

Achievements

Wendy joined Alimentiv in 2018 as part of our business development team and has been instrumental in shaping and growing our Precision Medicine team and service offering. Within the rapidly advancing precision medicine landscape, Wendy has a thorough knowledge of translational technologies and has established key collaborations and partnerships to ensure the successful delivery of custom solutions based on client needs.

Ethos

Life is a journey of discovery…ask questions often, keep an open mind and always be learning.

View Profile
Christopher Ma

MD, Senior Medical Director

Dr. Ma supports medical R&D projects.

Background

Dr. Ma obtained his MD from the University of Calgary in 2012. He completed his Internal Medicine residency at the University of Alberta, adult gastroenterology training at the University of Calgary and advanced IBD fellowships at the University of Calgary and Western University. In 2018, he completed a one-year Robarts IBD Clinical Trials Fellowship and in 2019 he earned an MPH in Epidemiology from Harvard University.

Ethos

“Teamwork is everything.”

View Profile
Gabriela Radulescu

Vice President, Medical Research and Development

Gabriela provides medical leadership for sponsor clinical trials, operational oversight for research and development projects, and medical input to the business development teams.

Background

Gabriela obtained her medical degree at the University of Medicine and Pharmacy Iuliu Hatieganu in Cluj – Napoca, Romania. Since then, she has acquired more than 20 years of experience working in the pharmaceutical industry in Canada in various leadership roles and across multiple functions including medical affairs, drug safety and pharmacovigilance, clinical research and real world evidence, and patient support programs. Prior to joining Alimentiv, Gabriela led a team of scientific professionals as a Medical Affairs Director in IBD.

Achievements

Since joining Alimentiv, through her multidisciplinary experience, Gabriela has been able to bring significant contributions to the development and implementation of organizational strategies and best practices. Her focus on the medical research and development area ensures a continued adherence to delivering high-quality research and science, superior customer service and people development.

Ethos

“I approach my role with the conviction that what we do matters for patients and physicians, and through our work we advance our mission to support human health. I believe it is important that every member of the Alimentiv team is authentic and brings their full contribution to the success of the organization.”

View Profile
Guangyong (GY) Zou

PhD - Biostatistician Director

After completing PhDs in Biostatistics and Plant Science from the University of Connecticut, Dr. Zou joined Alimentiv in September 2002. He is currently Professor of Epidemiology and Biostatistics at Western University.

Background

Dr. Zou oversees statistical support for Medical R&D programs, as well as Alimentiv IBD clinical research.

He has over 20 years of experience designing and analyzing clinical trials, including cluster randomization trials. His research has primarily focused on development and evaluation of statistical methods for medical research. At Alimentiv, he’s also researching endpoint development and validation, larger-scale effectiveness research and strategy trials.

He has published over 150 peer-reviewed articles, many of which have impacted medical and epidemiologic research. A single-authored 2004 article on regression models for estimating risk ratios has already received close to 3,000 citations.

Achievements

Dr. Zou wrote a 2004 paper on estimation of risk ratios that’s been cited close to 5,000 times, and a 2012 paper that Alimentiv uses to design reliability studies.

Ethos

“Results are only as good as the statistical methodology used to obtain them. My goal is to continuously create good statistical methodology for medical research.”

View Profile